TOVORAFENIB

TOVORAFENIB was reported 326 times

TOVORAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOTHALAMIC OBESITY 1 0.2500
1 ACUTE HAEMORRHAGIC CONJUNCTIVITIS 1 0.0333
2 INTRACRANIAL TUMOUR HAEMORRHAGE 10 0.0258
3 CUTIBACTERIUM ACNES INFECTION 1 0.0169
4 HYPERFIBRINOGENAEMIA 1 0.0149
5 EPHELIDES 6 0.0111
6 HAEMODILUTION 1 0.0101
7 MUCOCUTANEOUS TOXICITY 1 0.0095
8 HERPES ZOSTER MENINGOENCEPHALITIS 3 0.0083
9 PRODUCT GEL FORMATION 1 0.0082
10 PNEUMOCOCCAL BACTERAEMIA 1 0.0079
11 SUBARACHNOID HAEMATOMA 1 0.0075
12 THYMUS ENLARGEMENT 1 0.0063
13 TOXIC SHOCK SYNDROME STREPTOCOCCAL 1 0.0052
14 HAEMORRHAGIC CYST 2 0.0052
15 OCULAR ROSACEA 1 0.0049
16 EYELASH DISCOLOURATION 1 0.0046
17 PERIPHERAL VEIN THROMBOSIS 1 0.0042
18 GROWTH RETARDATION 12 0.0041
19 CREATINE KINASE INCREASED 3 0.0039
20 THUNDERCLAP HEADACHE 1 0.0038
21 CENTRAL PAIN SYNDROME 1 0.0038
22 SHUNT MALFUNCTION 1 0.0035
23 MELANOCYTIC NAEVUS 15 0.0034
24 CEREBRAL ASPERGILLOSIS 2 0.0033
25 CORNEAL INFILTRATES 1 0.0032
26 CENTRAL HYPOTHYROIDISM 1 0.0030
27 MYOSCLEROSIS 1 0.0027
28 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0022
29 CEREBRAL MICROHAEMORRHAGE 1 0.0022
30 BLOOD PHOSPHORUS DECREASED 8 0.0022
31 DISSEMINATED ASPERGILLOSIS 1 0.0021
32 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
33 EXPULSION OF MEDICATION 1 0.0019
34 TUMOUR HAEMORRHAGE 5 0.0018
35 DERMATITIS ACNEIFORM 10 0.0016
36 PNEUMONIA NECROTISING 1 0.0015
37 CELLULITIS STAPHYLOCOCCAL 1 0.0015
38 PNEUMOCOCCAL SEPSIS 1 0.0015
39 CEREBRAL CYST 1 0.0015
40 HAIR COLOUR CHANGES 18 0.0014
41 ACCIDENTAL UNDERDOSE 19 0.0013
42 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 1 0.0013
43 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
44 AMAUROSIS 1 0.0012
45 PERIORBITAL PAIN 1 0.0012
46 SKIN HYPOPIGMENTATION 2 0.0011
47 STREPTOCOCCAL BACTERAEMIA 1 0.0009
48 TUMOUR PSEUDOPROGRESSION 1 0.0009
49 METASTASES TO MENINGES 2 0.0009
50 XEROSIS 1 0.0008
51 OESOPHAGEAL HAEMORRHAGE 1 0.0008
52 MACULE 2 0.0007
53 PROTHROMBIN TIME SHORTENED 1 0.0007
54 NAIL INFECTION 1 0.0007
55 GINGIVAL HYPERTROPHY 1 0.0007
56 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
57 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
58 TYMPANIC MEMBRANE PERFORATION 1 0.0006
59 HYPOPITUITARISM 1 0.0006
60 MONOPARESIS 1 0.0006
61 PHOTOSENSITIVITY REACTION 9 0.0005
62 GRANULOCYTE COUNT DECREASED 1 0.0005
63 HYPERAEMIA 1 0.0005
64 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
65 BLEPHARITIS 2 0.0005
66 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
67 BRAIN OPERATION 1 0.0004
68 DIABETES INSIPIDUS 1 0.0004
69 PANNICULITIS 1 0.0004
70 HYPOPHOSPHATAEMIA 3 0.0004
71 HEPATIC ENZYME ABNORMAL 2 0.0004
72 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
73 MEAN CELL VOLUME INCREASED 1 0.0004
74 COMPARTMENT SYNDROME 1 0.0004
75 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
76 LARYNGOSPASM 1 0.0004
77 PSYCHOMOTOR RETARDATION 1 0.0004
78 SKIN TOXICITY 2 0.0004
79 RESPIRATORY SYMPTOM 1 0.0004
80 SKIN HYPERPIGMENTATION 3 0.0003
81 RETINAL VEIN OCCLUSION 1 0.0003
82 ADENOVIRUS INFECTION 1 0.0003
83 HAEMATOTOXICITY 3 0.0003
84 CEREBRAL HAEMATOMA 1 0.0003
85 B-CELL LYMPHOMA 1 0.0003
86 AMENORRHOEA 5 0.0003
87 FACIAL PARESIS 1 0.0003
88 HAEMORRHAGIC DIATHESIS 1 0.0003
89 WOUND HAEMORRHAGE 1 0.0003
90 PRODUCT ADMINISTRATION ERROR 5 0.0002
91 DEMYELINATION 1 0.0002
92 HYPERURICAEMIA 1 0.0002
93 DISEASE PROGRESSION 28 0.0002
94 HEPATIC CYTOLYSIS 3 0.0002
95 ABSCESS LIMB 1 0.0002
96 PRODUCT COMMUNICATION ISSUE 2 0.0002
97 DEVICE OCCLUSION 3 0.0002
98 BLOOD PROLACTIN INCREASED 1 0.0002
99 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
100 CEREBRAL ISCHAEMIA 1 0.0002
101 HYPERBILIRUBINAEMIA 2 0.0002
102 PARTIAL SEIZURES 1 0.0002
103 PRODUCT USE COMPLAINT 3 0.0002
104 PHARYNGITIS STREPTOCOCCAL 2 0.0002
105 SKIN LACERATION 2 0.0002
106 HYDROCEPHALUS 1 0.0002
107 NEUTROPHILIA 1 0.0002
108 PROTHROMBIN TIME PROLONGED 1 0.0002
109 ADRENAL INSUFFICIENCY 2 0.0002
110 HYPERCALCAEMIA 2 0.0002
111 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
112 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
113 BLOOD BILIRUBIN INCREASED 4 0.0001
114 COORDINATION ABNORMAL 2 0.0001
115 PAPULE 1 0.0001
116 TONGUE DISORDER 1 0.0001
117 ACNE 10 0.0001
118 DEVICE RELATED INFECTION 2 0.0001
119 PERICARDIAL EFFUSION 3 0.0001
120 ATRIOVENTRICULAR BLOCK 1 0.0001
121 EOSINOPHIL COUNT INCREASED 1 0.0001
122 VITAMIN D DECREASED 1 0.0001
123 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
124 EOSINOPHILIA 2 0.0001
125 DRUG ERUPTION 2 0.0001
126 HAEMOLYTIC ANAEMIA 1 0.0001
127 HEAVY MENSTRUAL BLEEDING 1 0.0001
128 LIP DRY 1 0.0001
129 CONJUNCTIVITIS 2 0.0001
130 ATELECTASIS 1 0.0001
131 LIGAMENT SPRAIN 1 0.0001
132 PRODUCT PHYSICAL ISSUE 2 0.0001
133 SUBARACHNOID HAEMORRHAGE 1 0.0001
134 PETECHIAE 1 0.0001
135 SCRATCH 1 0.0001
136 LIVER FUNCTION TEST INCREASED 2 0.0001
137 ASPIRATION 1 0.0001
138 RASH MACULO-PAPULAR 2 0.0001
139 GASTRIC HAEMORRHAGE 1 0.0001
140 LYMPHADENOPATHY 3 0.0001
141 COVID-19 PNEUMONIA 1 0.0001
142 BACTERAEMIA 1 0.0001
143 CYTOPENIA 1 0.0001
144 RESPIRATORY DEPRESSION 1 0.0001
145 BRAIN OEDEMA 1 0.0001
146 MYDRIASIS 1 0.0001
147 UVEITIS 1 0.0001
148 GINGIVAL BLEEDING 1 0.0001
149 HYPOMAGNESAEMIA 1 0.0001
150 OSTEOPENIA 1 0.0001
151 EJECTION FRACTION DECREASED 1 0.0001
152 NIGHT SWEATS 2 0.0001
153 RASH 27 0.0001
154 STAPHYLOCOCCAL INFECTION 2 0.0001
155 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
156 SKIN DISORDER 2 0.0001
157 CELLULITIS 3 0.0001
158 ISCHAEMIC STROKE 1 0.0001
159 THIRST 1 0.0001
160 CEREBRAL HAEMORRHAGE 2 0.0001
161 ACCIDENTAL OVERDOSE 2 0.0001
162 EPISTAXIS 4 0.0001
163 BLISTER 3 0.0001
164 HYPONATRAEMIA 3 0.0001
165 BLOOD SODIUM DECREASED 1 0.0001
166 HYPOCALCAEMIA 1 0.0001
167 FEELING JITTERY 1 0.0001
168 POST PROCEDURAL COMPLICATION 1 0.0001
169 HAEMATOCRIT DECREASED 1 0.0001
170 SPINAL FRACTURE 1 0.0000
171 RIB FRACTURE 1 0.0000
172 RHABDOMYOLYSIS 2 0.0000
173 DERMATITIS 1 0.0000
174 SWELLING FACE 3 0.0000
175 PRODUCT DISPENSING ERROR 1 0.0000
176 MUSCULOSKELETAL STIFFNESS 4 0.0000
177 STEVENS-JOHNSON SYNDROME 1 0.0000
178 TRANSAMINASES INCREASED 1 0.0000
179 RASH PAPULAR 1 0.0000
180 THERAPY NON-RESPONDER 2 0.0000
181 SKIN DISCOLOURATION 2 0.0000
182 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
183 AGEUSIA 1 0.0000
184 LEUKOPENIA 2 0.0000
185 HYPOPHAGIA 1 0.0000
186 HAEMOGLOBIN DECREASED 4 0.0000
187 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
188 OFF LABEL USE 34 0.0000
189 DIPLOPIA 1 0.0000
190 ECZEMA 2 0.0000
191 MUCOSAL INFLAMMATION 1 0.0000
192 SEDATION 1 0.0000
193 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
194 EAR INFECTION 1 0.0000
195 MENSTRUATION IRREGULAR 1 0.0000
196 JAUNDICE 1 0.0000
197 PNEUMONITIS 1 0.0000
198 ANAEMIA 7 0.0000
199 HAEMOPTYSIS 1 0.0000
200 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
201 HYPERSOMNIA 1 0.0000
202 LETHARGY 2 0.0000
203 SEIZURE 4 0.0000
204 ADVERSE DRUG REACTION 3 0.0000
205 STOMATITIS 2 0.0000
206 PLEURAL EFFUSION 2 0.0000
207 EPILEPSY 1 0.0000
208 EMOTIONAL DISORDER 1 0.0000
209 CYSTITIS 1 0.0000
210 MOOD SWINGS 1 0.0000
211 IMPAIRED HEALING 1 0.0000
212 URINARY RETENTION 1 0.0000
213 EYE PRURITUS 1 0.0000
214 FATIGUE 23 0.0000
215 MYALGIA 5 0.0000
216 HAEMATURIA 1 0.0000
217 NEOPLASM PROGRESSION 1 0.0000
218 WEIGHT DECREASED 8 0.0000
219 DEVICE MALFUNCTION 2 0.0000
220 HYPOXIA 1 0.0000
221 CONSTIPATION 6 0.0000
222 C-REACTIVE PROTEIN INCREASED 1 0.0000
223 AGITATION 2 0.0000
224 HEADACHE 17 0.0000
225 INTESTINAL OBSTRUCTION 1 0.0000
226 ERYTHEMA 5 0.0000
227 POLLAKIURIA 1 0.0000
228 BALANCE DISORDER 2 0.0000
229 VAGINAL HAEMORRHAGE 1 0.0000
230 SEPTIC SHOCK 1 0.0000
231 ANGIOEDEMA 1 0.0000
232 DRY SKIN 3 0.0000
233 GASTROINTESTINAL DISORDER 2 0.0000
234 THROAT IRRITATION 1 0.0000
235 NO ADVERSE EVENT 4 0.0000
236 OROPHARYNGEAL PAIN 2 0.0000
237 DECREASED APPETITE 5 0.0000
238 SWELLING 2 0.0000
239 RASH ERYTHEMATOUS 1 0.0000
240 CONTUSION 2 0.0000
241 INTERSTITIAL LUNG DISEASE 1 0.0000
242 HEART RATE INCREASED 2 0.0000
243 SOMNOLENCE 4 0.0000
244 THERAPY CESSATION 1 0.0000
245 NERVOUSNESS 1 0.0000
246 HAEMORRHAGE 2 0.0000
247 MUSCULOSKELETAL PAIN 1 0.0000
248 SPEECH DISORDER 1 0.0000
249 INSOMNIA 5 0.0000
250 RASH PRURITIC 1 0.0000
251 ANAPHYLACTIC REACTION 1 0.0000
252 ARTHROPATHY 1 0.0000
253 THROMBOCYTOPENIA 2 0.0000
254 OXYGEN SATURATION DECREASED 1 0.0000
255 EYE IRRITATION 1 0.0000
256 SURGERY 1 0.0000
257 IRRITABILITY 1 0.0000
258 VERTIGO 1 0.0000
259 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
260 PRODUCT USE ISSUE 3 0.0000
261 AMNESIA 1 0.0000
262 ALOPECIA 3 0.0000
263 HEPATIC ENZYME INCREASED 1 0.0000
264 NAUSEA 11 0.0000
265 RESPIRATORY FAILURE 1 0.0000
266 UNDERDOSE 1 0.0000
267 ASTHENIA 5 0.0000
268 DIABETES MELLITUS 1 0.0000
269 PRURITUS 5 0.0000
270 PERIPHERAL SWELLING 2 0.0000
271 VOMITING 6 0.0000
272 PNEUMONIA 4 0.0000
273 DRY MOUTH 1 0.0000
274 INFLUENZA LIKE ILLNESS 1 0.0000
275 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
276 RENAL IMPAIRMENT 1 0.0000
277 TACHYCARDIA 1 0.0000
278 CARDIAC DISORDER 1 0.0000
279 ANXIETY 3 0.0000
280 DYSPHAGIA 1 0.0000
281 PULMONARY EMBOLISM 1 0.0000
282 NEUROPATHY PERIPHERAL 1 0.0000
283 PRODUCT DOSE OMISSION ISSUE 3 0.0000
284 PAIN IN EXTREMITY 3 0.0000
285 FLUSHING 1 0.0000
286 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
287 ARTHRALGIA 4 0.0000
288 PLATELET COUNT DECREASED 1 0.0000
289 INFLUENZA 1 0.0000
290 WEIGHT INCREASED 2 0.0000
291 MUSCULAR WEAKNESS 1 0.0000
292 INCORRECT DOSE ADMINISTERED 2 0.0000
293 PYREXIA 3 0.0000
294 PAIN 5 0.0000
295 DEATH 7 0.0000
296 NEUTROPENIA 1 0.0000
297 VISION BLURRED 1 0.0000
298 COUGH 2 0.0000
299 INFECTION 1 0.0000
300 HOSPITALISATION 1 0.0000
301 CONFUSIONAL STATE 1 0.0000
302 TREMOR 1 0.0000
303 DIZZINESS 3 0.0000
304 URTICARIA 1 0.0000
305 ABDOMINAL DISCOMFORT 1 0.0000
306 TOXICITY TO VARIOUS AGENTS 1 0.0000
307 URINARY TRACT INFECTION 1 0.0000
308 COVID-19 1 0.0000
309 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
310 MUSCLE SPASMS 1 0.0000
311 NASOPHARYNGITIS 1 0.0000
312 HYPERSENSITIVITY 1 0.0000
313 ABDOMINAL PAIN 1 0.0000
314 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
315 CONDITION AGGRAVATED 1 0.0000
316 FALL 1 0.0000
317 DRUG INEFFECTIVE 3 0.0000
318 DIARRHOEA 1 0.0000